Cytokine phenotypes serve as a paradigm for experimental immune-mediated lung diseases and remodeling

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 3 II, 2003, Pages

  Kunkel, Steven L ^a   Chensue, Stephen W ^a   Lukacs, Nicholas ^a   Hogaboam, Cory ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; CYTOKINE; CYTOKINE TYPE 2; INTERLEUKIN 13; UNCLASSIFIED DRUG;

CELL ACTIVATION; CHEMOTAXIS; CHRONIC LUNG DISEASE; CONFERENCE PAPER; DISEASE COURSE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE; LUNG FIBROSIS; LUNG INTERSTITIUM; PATHOGENESIS; PHENOTYPE; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT PLANNING;

ANIMALS; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG DISEASES; PHENOTYPE; PULMONARY FIBROSIS; TH1 CELLS; TH2 CELLS;

ANIMALIA;

EID: 0042829327     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Chensue, S. W., K. Warmington, J. H. Ruth, N. Lukacs, and S. L. Kunkel. 1997. Mycobacterial and schistosomal antigen-elicted granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J. Immunol. 159:3565-3573.
2. Czaja, M. J., F. R. Weiner, S. Takahashi, M. A. Giambrone, P. H. Van der Meide, H. Schellenkens, L. Biempica, and M. A. Zern. 1989. Gamma interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatol. 10:795-800.
3. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-596.
4. Oriente, A. O., N. S. Fedarko, S. E. Pacocha, S. K. Huang, L. M. Lichtenstein, and D. E. Essayan. 2000. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J. Pharm. Exp. Ther. 292:988-994.
5. Gillery, P., C. Fertin, J. F. Nicolas, F. Chastang, B. Kalis, J. Banchereau, and F. X. Maquart. 1992. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures: potential role in fibrosis. FEBS Lett. 302:231-234.
6. Goldman, M., D. Druet, and E. Gleichmann. 1991. Th2 cells in systemic autoimmunity: insights from allogeneic disease and chemically-induced autoimmunity. Immunol. Today 12:223-228.
7. Ushiyama, C., T. Hirano, H. Miyajima, K. Okumura, Z. Ovary, and H. Hashimoto. 1995. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. J. Immunol. 154:2687-2696.
8. Glazier, A., J. Tutschka, E. R. Farmer, and G. W. Santos. 1983. Graft-vs-host disease in cyclosporin rats after syngeneic and autologous bone marrow reconstitution. J. Exp. Med. 158:1-13.
9. Weller, P. A. 1989. Eosinophils and fibroblasts: the medium in the mesenchyme. Am. J. Respir. Cell Mol. Biol. 1:267-268.
10. Lee, C. G., R. J. Homer, Z. Zhu, S. Lanone, X. Wnag, V. Koteliansky, M. Shipley, P. Nobel, Q. Chen, R. M. Senior, and J. A. Elias. 2002. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta1. J. Exp. Med. 194:809-821.
11. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, abnormalities, and eotaxin production. J. Clin. Invest. 103:779-788.
12. Sime P, Z. Xing, F. L. Graham, K. G. Csaky, and J. Gauldie. 1997. Adenovectormediated gene transfer of active transforming growth factor beta1 induces prolonged sever fibrosis in rat lung. J. Clin. Invest. 100:768-776.
13. Zhu, Z., B. Ma, T. Zheng, R. J. Homer, C. G. Lee, I. F. Charo, P. Noble, and J.A. Elias. 2002. IL-13 induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 68:2953-2962.
14. Chiaramonte, M. G., D. D. Donaldson, A. W. Cheever, and T. A. Wynn. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2- dominated inflammatory response. J. Clin. Invest. 104:777-785.
15. Kaplan, M. H., J. R. Whitfield, D. L. Boros, and M. J. Grusby. 1998. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J. Immunol. 160:1850-1856.
16. Blease, K., C. Jakubzick, J. M. Schuh, B. H. Joshi, R. K. Puri, and C. M. Hogaboam. 2001. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J. Immunol. 167:6583-6592.
17. Jakubzick, C., S. L. Kunkel, B. H. Joshi, R. J. Puri, and C. M. Hogaboam. 2002. Interleukin-13 fusion cytotoxin arrests Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am. J. Pathol. 161:1283-1297.
18. Gharaee-kermani, M., E. M. Denholm, and S. H. Phan. 1996. Costimulation fo fibroblast collagen and transforming growth factor beta 1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 271:17779-17784.
19. Iyonaga, K., M. Takeya, N. Saita, O. Sakamoto, T. Yoshimura, M. Ando, and K. Takahashi. 1994. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum. Pathol. 25:455-460.
20. Lloyd, C. M., A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. Wells, D. J. Salant, and J. C. Guitierrez-Ramos. 1997. RANTES and monocyte chemoattractant protein-1 play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185:1371-1378.
21. Hogaboam, C. M., R. E. Smith, and S. L. Kunkel. 1998. Dynamic interactions between lung fibroblasts and leukocytes: Implications for fibrotic lung disease. Proceedings of the Association of American Physicians 110:313-320.